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Abstract
Granular cell tumor is rare and accounts for approximately 0.5 % of all soft tissue tumors. The malignant granular cell
tumor, especially cutaneous malignant granular cell tumor is extremely rare. The present case is the first patient of
primary cutaneous malignant granular cell tumor reported from China in English. A review of the literature is
performed, and the presentation, position, pathological diagnosis, treatment and prognosis of the patients with
cutaneous malignant granular cell tumor of the reported cases before is analysed.
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Background
Granular cell tumor is rare and accounts for approximately
0.5 % of all soft tissue tumors [1]. The frequent locations of
the tumor are tongue (40 %), breast (15 %), respiratory tract
(10 %) and oesophagus (2 %). Granular cell tumor can be
multicentric (5 % to 14 % of cases) [2]. The malignant
granular cell tumors (MGCT) are extremely rare represent-
ing less than 0.5 % to 2 % of all granular cell tumors and
more likely to attack blacks than whites and are two times
more likely to occur in females than males [3]. Both benign
and malignant granular cell tumors have been found in a
wide variety of locations, including lung, heart, pelvis,
bladder, vulva, abdominal wall, and esophagus [4–12]. Local
recurrence and metastasis of MGCT is potentially higher
with poor prognosis than the benign counterparts. MGCT
also typically develop in the lower extremity, often the
thigh, whereas the benign tumors more commonly occur in
the head and neck, most commonly the tongue. The most
common metastasis sites are regional lymph nodes, lungs,
and bones [13]. Primary cutaneous malignant granular cell
tumor is very rare, here we report a case and review literature.
Case presentation Clinical history
A 66-year-old man presented with a mass in the skin of the
right abdominal wall, which was first noted approximately
three years ago, however the size of the mass has been
increased gradually over the past six months without pain.
On examination, a well-localized, about 3.0 cm in diameter
soft tissue mass was clinically located in the skin and bulged
from the right abdomen wall. The patient was otherwise
well, with no other medical conditions. There was no family
history of any malignancy or cutaneous lesions. Local exci-
sion was performed for the primary tumor. No dissection of
lymph nodes and adjuvant treatment was performed. The
patient is well, without recurrence one year after surgery.
Pathology
Gross
The mass was firm and well circumscribed with 3.0 cm in
diameter and bulge from the skin with 2.8 cm high. The surface
of the mass was rough with ulceration and the section was gray
white with toughness. The tumor was located in the dermis
and the subcutis and invaded to the subcutaneous fat layer with
the normal structure of the skin disappeared (Fig. 1a and b).
Histology and Immunohistochemistry
The tumor and the other abscised tissues were fixed in 10 %
formalin and embedded in paraffin. Several 4-μm sections
were cut from each paraffin block, and one was stained with
HE (hematoxylin and eosin), the others were stained with
IHC (immunohistochemistry). Immunohistochemical stain-
ing was performed using the streptavidin-peroxidase system
(Ultrasensitive; Mai Xin Inc., Fuzhou, China) according to
the manufacturer’s instruction. Commercially available pre-
diluted monoclonal antibodies against the following antigens
were employed: vimentin, S100, NSE and CD68, cytokeratin
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(with CAM 5.2 and KL-1), actin (smooth muscle), desmin,
GFAP, EMA, CD34, HMB45 and NF-LH(all Thermo Fisher
Scientific Inc., Fremont, CA, USA). Histologically, the tumor
was composed of aggregates and sheets of intermediate size
spindle and polyhedral cells that had granular eosinophilic
cytoplasm. The nuclei were vesicular with prominent
nucleoli. Mitoses were numerous with 1 mitoses per 10
high-power fields. High nucleocytoplasmic ratio was
present. No definite necrosis (Fig. 2). Immunohistochemis-
try was positive for vimentin, S100, NSE and CD68, and
negative for cytokeratin (with CAM 5.2 and KL-1), actin
(smooth muscle), desmin, GFAP, EMA, CD34, HMB45 and
Fig 1 a, The mass bulged from the skin with a rough surface, ulceration and necrosis. The mass was well circumscribed with 3.0 cm in diameter and
bulged from the skin with 2.8 cm high; b, The section was firm and gray white with toughness. The normal structure of the skin disappeared and the
tumor invasion to the subcutaneous fat layer
Fig 2 a and b, the tumor was composed of aggregates and sheets of intermediate size spindle and polyhedral cells that had granular eosinophilic
cytoplasm, A, H-E stain, 40× and B, H-E stain, 100×; c and d, H-E stain, 200×; e and f, high nucleocytoplasmic ratio, vesicular nuclei with prominent
nucleoli, the arrows show mitoses, H-E stain, 400 ×
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NF-LH. The proliferation rate assessed by the Ki-67 (MIB-
1) stain was about 10 % (Fig. 3).
Conclusions
Histologically, the tumor was composed of aggregates
and sheets of intermediate size spindle and polyhedral
cells that had granular eosinophilic cytoplasm. Mitoses
were numerous with 1 mitoses per 10 high-power fields.
Immunohistochemistry was positive for vimentin, S100,
NSE and CD68, and negative for cytokeratin, actin
(smooth muscle), desmin, GFAP, EMA, CD34, HMB45
and NF-LH. Ki-67 (MIB-1) stain was about 10 %. The
diagnosis of primary cutaneous malignant granular cell
tumor was made.
Fig 3 a, vimentin, 200×; b, NSE, 200×; c, S-100, 200×; d, CD68, 200×; e, Ki-67, 200×; f, CK, 200×; g, Desmin, 200×; h, GFAP, 100 ×
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Discussion
Granular cell tumor was first described in German lit-
erature in 1926 and named myoblastoma, with believed
to be of myogenic origin because of its origin from the
tongue muscle [23]. The tumor was thought to have a
neural origin because it was assumed to be from the
radial and sciatic nerves within the extremities in 1960s
[14]. Recent decades, Schwannian features have been
documented ultrastructurally and immunohistochemi-
cally [15–19]. This rare tumor can affect various regions
of the body, but more frequently found in the head and
neck commonly involving the tongue. Primary cutaneous
malignant granular cell tumor is very rare.
In China, there is only one case report of primary cutane-
ous malignant granular cell tumor in Chinese. A 55-year-
old women, a farmer, complained of a hard nodule, which
diameter was 2.5 cm, on the back for about 1 year. The
patient had a good condition after surgery and still under
follow up since the paper was published [24].
Here, we present a Chinese patient of primary malig-
nant granular cell tumor of cutaneous. The tumor was
firm and well circumscribed with 3.0 cm in diameter
and bulge from the skin with 2.8 cm high. The surface
of the mass was rough with ulceration and the section
was gray white with toughness. Histologically, the tumor
was composed of aggregates and sheets of intermediate
size spindle and polyhedral cells that had granular eo-
sinophilic cytoplasm. The nuclei were vesicular with
prominent nucleoli. Immunohistochemistry was positive
for vimentin, S100, NSE and CD68. The proliferation
rate assessed by the Ki-67 (MIB-1) stain was about 10 %.
Granular cell tumor usually presents with a painless
mass occurring most during 30–50 years old. Women
are more commonly affected with a ratio of 1.8-2.9:1 to
men. The best imaging modality for the characterization
of this tumor is magnetic resonance imaging (MRI)[14].
Clinical findings for prediction of malignancy includes
large tumor size (>5 cm), older age, female gender, oval
or round shape, deep location (intramuscular), occur-
rence in the lower extremities, rapid recent growth after
an extended period, and local recurrence [20]. The differen-
tial diagnosis of MGCT includes renal cell carcinoma,
rhabdomyosarcoma, and alveolar soft part sarcoma, ect.
However, the diagnosis usually can be confirmed by the
histomorphology and immunohistochemical profile.
Fanburg-Smith et al. reported histologic criteria for
MGCT by analyzing the clinical and histologic data of 73
cases of granular cell tumors. According to their report, the
six features include necrosis, spindling, vesicular nuclei with
large nucleoli, increased mitotic activity (>2 mitoses/10
high-power fields at 200× magnification), high nuclear to
cytoplasmic (N:C) ratio, and pleomorphism. Neoplasms
that met three or more of these criteria were classified as
histologically malignant, which may result in death in
40 % of cases because of the high chance of local recur-
rence and metastasis. Those that met one or two criteria
were classified as atypical; and those that displayed only
focal pleomorphism but fulfilled none of the other criteria
were classified as benign with no metastasis or local recur-
rence after adequate resection. Poor prognostic factors
associated with MGCT include large tumor size, older
patient age, increased mitotic activity and Ki-67 greater
than 10 % [21].
Surgical excision with a clean margin is the best treat-
ment for this tumor although it is not always possible
because of lacking a complete capsule. In addition to the
incidence of recurrence and metastasis and the rapidity
of tumor growth, a second operation and postoperative
chemotherapy and/or radiation should be considered.
Local recurrence and metastasis are relatively common in
MGCT, with 32 % rate of recurrence and 50 % metastasis
in the Fanburg-Smith analysis [21]. Distant and lymph node
metastases are common, presenting between 3 and
37 months after initial diagnosis, and distal metastases
often occur in the lung, liver and bone [13, 20–22]. Thus, a
sentinel lymph node biopsy during the initial surgical resec-
tion should be necessary.
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